Figure 6.
Multiple independent VELUCT-specific silencing reagents reduced viability of other lung cancer cell lines. H1437 and H1944 cells were transfected with 30 nM siRNAs (A), siPOOLs (B) or ASOs (C) targeting VELUCT. Cell viability was measured 72 h after transfection and normalized to the respective NC. Bars show mean ± SD (n = 4–5). *P < 0.05, **P < 0.01, ***P < 0.001.